Skip to main content

Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion

Annals of Ophthalmology volume 39, pages 307–312 (2007)Cite this article

Abstract

We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term.

This is a preview of subscription content, access via your institution.

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M Report. Ophthalmology 1995;102:1425–1433

    Google Scholar 

  2. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219–221

    PubMed  CAS  Google Scholar 

  3. Opremcak EM, Bruce RA, Lomeo M, et al. Radial optic neurotomy for central retinal vein occlusion. Retina 2001;21:408–415

    PubMed  Article  CAS  Google Scholar 

  4. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249–2257

    PubMed  Article  CAS  Google Scholar 

  5. McAllister IL, Douglas JP, Constable IJ, et al. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Am J Ophthalmol 1998;126:219–229

    PubMed  Article  CAS  Google Scholar 

  6. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247–248

    PubMed  Article  Google Scholar 

  7. Jonas JB, Hayler JK, Söfker A, et al. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001;131:468–471

    PubMed  Article  CAS  Google Scholar 

  8. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979;77:171–180

    PubMed  CAS  Google Scholar 

  9. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003;136:419–425

    PubMed  Article  CAS  Google Scholar 

  10. Bashshur ZF, Ma’luf RN, Allam S, et al. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 2004;122:1137–1140

    PubMed  Article  CAS  Google Scholar 

  11. Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 2005;83:71–75

    PubMed  Article  CAS  Google Scholar 

  12. Sidney S, Castellan J. Nonparametric Statistics for the Behavioral Sciences. NewYork: McGraw-Hill, 1988, Ch 7, pp. 174–183

  13. Nauck M, Karakiulais G, Perruchoud AP, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309–315

    PubMed  Article  CAS  Google Scholar 

  14. Nauck M, Roth M, Tamm M, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth-factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 1997;16:398–406

    PubMed  CAS  Google Scholar 

  15. Danis RP, Ciulla TA, Pratt LM, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244–250

    PubMed  Article  CAS  Google Scholar 

  16. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefe’s Arch Clin Exp Ophthalmol 2002;240:782–783

    Article  Google Scholar 

  17. Ip M, Kumar KS. Intravitreal triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217–1219

    PubMed  Google Scholar 

  18. Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004;122:1131–1136

    PubMed  Article  CAS  Google Scholar 

  19. Ip M, Kahana A, Altaweel M. Treatment of central vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol 2003;18:67–73

    PubMed  Article  Google Scholar 

  20. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920–927

    PubMed  Article  Google Scholar 

  21. Antcliff RJ, Spalton DJ, Stanford MR, et al. Uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765–772

    PubMed  Article  CAS  Google Scholar 

  22. Jonas JB, Kreissig I, Degenring RF. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24–27

    PubMed  Article  CAS  Google Scholar 

  23. Kaushik S, Gupta V, Gupta A, et al. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol 2004;137:758–760

    PubMed  CAS  Google Scholar 

  24. Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular edema due to central retinal vein occlusion. Acta Ophthalmol Scand 2005;83:71–75

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Ophthalmology, Faculty of Medicine, Ankara University, Ankara, Turkey

    Figen Batioglu MD, Emin Özmert MD & Elif Akmese MD

  2. Angora Evleri Meriç sokak No:30, Beysukent, Ankara, Turkey

    Figen Batioglu MD

Authors
  1. Figen Batioglu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emin Özmert MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elif Akmese MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Figen Batioglu MD.

Additional information

Drs. Batioglu, Özmert and Akmese are from the Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey.

The authors have stated that they do not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The authors do not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.

The authors treated macular edema due to central retinal vein occlusion with intravitreal triamcinolone injection. Therapy improved anatomy in the short term, but recurrences and steroid-related complications were noted in the longer term.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Batioglu, F., Özmert, E. & Akmese, E. Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion. Ann Ophthalmol 39, 307–312 (2007). https://doi.org/10.1007/s12009-007-9016-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12009-007-9016-x

Keywords

  • Optical Coherence Tomography
  • Macular Edema
  • Intravitreal Injection
  • Diabetic Macular Edema
  • Cystoid Macular Edema